HMGB1 and metabolic dysfunction-associated steatotic liver disease: Extracellular HMGB1, an endogenous danger molecule, has been reported to trigger innate immune activation-mediated inflammatory response under various pathological conditions, including NAFLD (Li et al. 2011; Lundbäck et al. 2016).